Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, GOOD JENNIFER L, holds the title of Director at RHYTHM PHARMACEUTICALS, INC..
On 2026-06-23, the insider transacted 4,712 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
GOOD JENNIFER L (Director) exercised options for $0 of $RYTM
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.